Prix Galien USA

CUTISS has been nominated for the 2025 edition of the Prix Galien USA, which recognizes outstanding advances in medical and pharmaceutical innovation.

The nomination highlights our work in personalized regenerative medicine and the clinical development of denovoSkin™ as a novel skin tissue therapy for patients with severe skin injuries.
The awards ceremony in New York City brought together leading innovators from around the world.

More information

Details

1360 Rte des Dolines, 06560 Valbonne, France

CUTISS AG

Associated Trend items

First U.S. compassionate use of denovoSkin™ !

New publication reports U.S. compassionate use of denovoSkin™ in pediatric reconstructive surgery

A new peer-reviewed report in the Journal of Burn Care & Research describes the compassionate use of denovoSkin™ in a pediatric patient with extensive burn injuries treated at Massachusetts General Hospital (Boston, USA). The publication details reconstructive procedures including contracture release and treatment of unstable scars, reporting high engraftment rates, dura...

More information

CUTISS wins 2nd place at The Spark Award 2025

CUTISS has been awarded 2nd place at the 2025 edition of The Spark – Der Deutsche Digitalpreis, which recognizes outstanding deep-tech innovation across Germany, Austria, and Switzerland.

The award ceremony in Munich brought together finalists from across a range of industries. CUTISS was recognized for its pioneering work in personalized regenerative medicine, and for combining bioengineering with automation to transform skin surgery for patients with severe skin injuries. This marks the first time a Swiss company has received an award at The Spark, a mi...

More information

Products associated

non cultured epidermal cell grafting kit

VitiCell®

Compare

Remove all

Compare up to 10 products